Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Lily Guo
 + 393 word(s) 393 2020-12-15 08:00:30 |
2 format change
Lily Guo
 -6 word(s) 387 2020-12-22 09:56:41 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Guo, L. MEFV Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/3745 (accessed on 01 May 2024).
Guo L. MEFV Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/3745. Accessed May 01, 2024.
Guo, Lily. "MEFV Gene" Encyclopedia, https://encyclopedia.pub/entry/3745 (accessed May 01, 2024).
Guo, L. (2020, December 22). MEFV Gene. In Encyclopedia. https://encyclopedia.pub/entry/3745
Guo, Lily. "MEFV Gene." Encyclopedia. Web. 22 December, 2020.
MEFV Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/mefv

MEFV, pyrin innate immunity regulator

genes

1. Introduction

The MEFV gene provides instructions for making a protein called pyrin (also known as marenostrin). Although pyrin's function is not fully understood, it likely assists in keeping the inflammation process under control. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. When this has been accomplished, the body stops the inflammatory response to prevent damage to its own cells and tissues.

Pyrin is produced in certain white blood cells (neutrophils, eosinophils, and monocytes) that play a role in inflammation and in fighting infection. Pyrin may direct the migration of white blood cells to sites of inflammation and stop or slow the inflammatory response when it is no longer needed. Pyrin also interacts with other molecules involved in fighting infection and in the inflammatory response. Research indicates that pyrin helps regulate inflammation by interacting with the cytoskeleton, the structural framework that helps to define the shape, size, and movement of a cell.

2. Health Conditions Related to Genetic Changes

2.1. Familial Mediterranean fever

More than 80 MEFV gene mutations that cause familial Mediterranean fever have been identified. A few mutations delete small amounts of DNA from the MEFV gene, which can lead to an abnormally small, nonfunctional protein. Most MEFV gene mutations, however, change one of the protein building blocks (amino acids) used to make pyrin. The most common mutation replaces the amino acid methionine with the amino acid valine at protein position 694 (written as Met694Val or M694V). Among people with familial Mediterranean fever, this particular mutation is also associated with an increased risk of developing amyloidosis, a complication in which abnormal protein deposits can lead to kidney failure. Some evidence suggests that variations in another gene, called SAA1, can further modify the risk of developing amyloidosis among people with the M694V mutation.

MEFV gene mutations lead to reduced amounts of pyrin or a malformed pyrin protein that cannot function properly. As a result, pyrin cannot perform its presumed role in controlling inflammation, leading to an inappropriate or prolonged inflammatory response. Fever and inflammation in the abdomen, chest, joints, or skin are signs of familial Mediterranean fever.

3. Other Names for This Gene

  • FMF
  • marenostrin
  • Mediterranean fever
  • MEF
  • MEFV_HUMAN
  • MRST
  • pyrin
  • TRIM20

References

  1. Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, Oddoux C, Wood G, Azzaro MP, Palumbo G, Giustolisi R, Pras M, Ostrer H, Kastner DL.Mutation and haplotype studies of familial Mediterranean fever reveal newancestral relationships and evidence for a high carrier frequency with reducedpenetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999Apr;64(4):949-62.
  2. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol. 2003Sep;18(9):853-9.
  3. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. TheB30.2 domain of pyrin, the familial Mediterranean fever protein, interactsdirectly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U SA. 2006 Jun 27;103(26):9982-7.
  4. Delibaş A, Oner A, Balci B, Demircin G, Bulbul M, Bek K, Erdoğan O, Baysun S, Yilmaz E. Genetic risk factors of amyloidogenesis in familial Mediterraneanfever. Am J Nephrol. 2005 Sep-Oct;25(5):434-40.
  5. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. Thecontribution of genotypes at the MEFV and SAA1 loci to amyloidosis and diseaseseverity in patients with familial Mediterranean fever. Arthritis Rheum. 2003Apr;48(4):1149-55.
  6. Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM, Aksentijevich I,Kastner DL. The familial Mediterranean fever protein, pyrin, associates withmicrotubules and colocalizes with actin filaments. Blood. 2001 Aug 1;98(3):851-9.
  7. Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G,Loiselet J, Mégarbané A. Amyloidosis in familial Mediterranean fever patients:correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC MedGenet. 2004 Feb 10;5:4.
  8. Mikula M, Buller A, Sun W, Strom CM. Prevalence of known mutations in thefamilial Mediterranean fever gene (MEFV) in various carrier screeningpopulations. Genet Med. 2008 May;10(5):349-52. doi: 10.1097/GIM.0b013e3181723cc8.
  9. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I,Lesage S, Waterham H, Wise C, Sarrauste de Menthiere C, Touitou I. The infeversautoinflammatory mutation online registry: update with new genes and functions.Hum Mutat. 2008 Jun;29(6):803-8. doi: 10.1002/humu.20720.
  10. Notarnicola C, Didelot MN, Koné-Paut I, Seguret F, Demaille J, Touitou I.Reduced MEFV messenger RNA expression in patients with familial Mediterraneanfever. Arthritis Rheum. 2002 Oct;46(10):2785-93.
  11. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grütter C,Grütter M, Tschopp J. The SPRY domain of Pyrin, mutated in familial Mediterraneanfever patients, interacts with inflammasome components and inhibits proIL-1betaprocessing. Cell Death Differ. 2007 Aug;14(8):1457-66.
  12. Rabinovitch E, Harats D, Yaron P, Luvish T, Lidar M, Kedem R, Shaish A,Ben-Dov I, Livneh A. Familial Mediterranean fever gene and protection againstasthma. Ann Allergy Asthma Immunol. 2007 Dec;99(6):517-21. doi:10.1016/S1081-1206(10)60380-8.
  13. Ross JJ. Goats, germs, and fever: Are the pyrin mutations responsible forfamilial Mediterranean fever protective against Brucellosis? Med Hypotheses.2007;68(3):499-501.
  14. Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, Danon Y, Halpern GJ, Lifshitz Y, Shohat M. Higher than expected carrier rates for familialMediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000Apr;8(4):307-10.
  15. Telatar M, Grody WW. Molecular genetic testing for familial Mediterraneanfever. Mol Genet Metab. 2000 Sep-Oct;71(1-2):256-60. Review.
  16. Yepiskoposyan L, Harutyunyan A. Population genetics of familial Mediterranean fever: a review. Eur J Hum Genet. 2007 Sep;15(9):911-6.
  17. Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L, McCormickM, Zhang Z, Alnemri ES. Pyrin activates the ASC pyroptosome in response toengagement by autoinflammatory PSTPIP1 mutants. Mol Cell. 2007 Oct26;28(2):214-27.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Lily Guo
View Times: 330
Entry Collection: MedlinePlus
Revisions: 2 times (View History)
Update Date: 22 Dec 2020
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback